You are here

lambrolizumab

Markets That Can Propel Merck

Forbes

Thu, 12/19/13 - 05:12 pm

5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer

Motley Fool

Sun, 09/22/13 - 11:23 am

Peregrine Pharmaceuticals

Bristol-Myers Squibb

Clovis Oncology

Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition

Seeking Alpha

Mon, 08/12/13 - 09:11 am

non-small cell lung cancer

Where Is Biotechnology's Next 'Anti-PD-1'?

Seeking Alpha

Tue, 06/18/13 - 09:50 am

anti-PD-1 immunotherapy

Bristol-Myers Squibb

Baxter International

These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status

Yahoo/Street Authority

Fri, 06/14/13 - 12:21 pm

breakthrough therapies

Merck jumps on melanoma treatment results

Marketwatch

Mon, 06/3/13 - 11:26 am

Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.

TheStreet.com

Mon, 06/3/13 - 10:20 am

Bristol-Myers Squibb

Merck Rushes Forward In Race To Market Cell Death Cancer Drugs

Forbes

Sun, 06/2/13 - 11:56 am

Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'

Seeking Alpha

Wed, 05/22/13 - 09:35 am

breakthrough therapies

Bristol Myers Squibb And The New Wave Of Cancer Drugs

Seeking Alpha

Mon, 05/20/13 - 05:26 pm

Bristol-Myers Squibb

Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy

Yahoo/AP

Wed, 04/24/13 - 09:34 am